CSIMarket
 
Acorda Therapeutics Inc   (ACOR)
Other Ticker:  
 
 

Acorda Therapeutics Inc Balance Sheet Annual

ACOR


Select the Financial Report:   Period:   Fiscal Year:




ACOR Balance Sheets
(Annual, GAAP in millions $)

(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
ASSETS
Cash & cash equivalent 37.54 45.63 71.37 62.09 293.56
Restricted Cash and Cash Equivalents, Current - - - - 0.53
Short-term Investments, Total - - - 63.75 151.99
Cash & Short-term Investments 37.54 45.63 71.37 125.84 446.09
Accounts receivable 13.87 17.00 20.19 22.08 23.43
Other Receivables - - - - -
Notes Receivable, Current - - - - -
- - 71.80 - -
Inventories 12.75 18.55 28.68 25.22 29.01
Other Current Assets 13.65 14.40 86.29 16.40 10.19
Prepaid Expense, Current AS 4.31 6.57 14.81 11.57 19.38
Total Current Assets 82.12 102.16 221.34 201.11 528.11
Equipment/Property/Plant Net 2.60 4.38 7.26 142.53 60.52
Goodwill net - - - - 282.06
Intangible Assets 305.09 335.98 366.98 402.33 428.57
Long-term investments - - - - -
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Deferred Tax Assets, Net, Noncurrent AS - - - - -
Other Assets, Noncurrent 5.79 12.95 37.10 53.75 0.41
Deferred Costs, Noncurrent AS - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 395.60 455.47 632.68 799.72 1,299.67
LIABILITIES
Accounts Payable, Current AC 9.81 10.85 12.16 26.26 48.86
Accrued Liabilities, Current AC 23.68 28.61 38.17 39.08 76.88
Derivative Liability, Current DE - - - - -
Loans Payable, Current NO - - 68.63 0.60 0.62
Other Liabilities, Current 1.55 12.65 16.68 18.58 -
Taxes Payable - - - - -
Deferred Revenue, Current DE 0.38 - - - -
Business Combination, Contingent Consideration, Liability, Current BU 2.53 1.93 1.62 1.87 4.91
Current Liability Related To Sale Of Future Royalties - 4.46 8.73 - 8.99
Deferred Product Revenue Current Product Two - - - - -
Total Current Liabilities 37.95 54.03 137.25 86.39 140.26
Long-term debt - 27.65 28.56 25.50 24.47
Capital Lease and Other - - - - -
Convertible Debt, Noncurrent LO 167.03 151.03 137.62 192.77 318.67
Total Long-term Debt 167.03 178.67 166.17 218.27 343.14
Derivative Liability, Noncurrent DE - 0.04 1.19 59.41 -
Employee Benefit Plans, Noncurrent - - - - -
Deferred Revenue, Noncurrent DE - - - - -
Deferred Tax Liabilities, Net LI - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent - 71.60 90.11 124.84 204.29
Deferred Income Tax Liabilities Net 44.20 13.93 19.12 - -
Total Liabilities 204.98 304.33 394.73 488.90 687.68
SHAREHOLDER'S EQUITY
Common Stock Value 0.02 0.01 0.01 0.05 0.05
Treasury Stock Value -0.64 -0.64 -0.64 -0.64 -2.13
Additional Paid In Capital Common Stock 1,029.88 1,023.14 1,007.79 979.39 1,005.11
Retained Earnings / Accumulated Deficit -936.27 -870.36 -766.40 -666.81 -393.84
Other Equity 0.63 -1.02 -2.80 -1.17 2.81
Noncontrolling interests & other - - - - -
Total Stockholder's Equity 93.62 151.14 237.96 310.82 611.98
Liabilities & Stockholder's Equity 395.60 455.47 632.68 799.72 1,299.67






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com